Role of High-Risk HPV Testing in Papanicolaou Tests With Atypical Glandular Cells With and Without Concurrent Squamous Cell Abnormalities
LH Lin, MN Koloori, TC Brandler… - American Journal of …, 2022 - academic.oup.com
Abstract Objectives Data on Papanicolaou (Pap) tests with atypical glandular cells (AGCs)
with concurrent squamous cell abnormalities (AGC+ Sq) are limited. We evaluated histologic …
with concurrent squamous cell abnormalities (AGC+ Sq) are limited. We evaluated histologic …
Endocervical glandular involvement is associated with an increased detection rate of high-grade squamous intraepithelial lesions on the Papanicolaou test
R Jones, F Dale, JJ Fite, ML Cowan… - Journal of the American …, 2020 - Elsevier
Introduction Although The Bethesda System for Reporting Cervical Cytopathology does not
mandate reporting of endocervical glandular involvement (EGI) in Papanicolaou test …
mandate reporting of endocervical glandular involvement (EGI) in Papanicolaou test …
Молекулярный Пап-тест в постменопаузе
НВ Мельникова, МВ Захаренко… - Вестник Российского …, 2019 - cyberleninka.ru
В работе проанализированы перспективы дифференциальной диагностики
предраковых процессов и рака шейки матки у женщин в постменопаузе. Впервые …
предраковых процессов и рака шейки матки у женщин в постменопаузе. Впервые …